References
- Lee MR, Shumack S. Prurigo nodularis: A review. Australas J Dermatol. 2005;46(4):211–218.
- Winhoven SM, Gawkrodger DJ. Nodular prurigo: Metabolic diseases are a common association. Clin Exp Dermatol. 2007;32(2):224–225.
- Schneider G, Hockmann J, Ständer S, Luger TA, Heuft G. Psychological factors in prurigo nodularis in comparison with psoriasis vulgaris: Results of a case–control study. Br J Dermatol. 2006;154(1):61–66.
- Ständer S, Luger T, Metze D. Treatment of prurigo nodularis with topical capsaicin. J Am Acad Dermatol. 2001;44(3):471–478.
- Saraceno R, Nisticò SP, Capriotti E, de Felice C, Rhodes LE, Chimenti S. Monochromatic excimer light (308 nm) in the treatment of prurigo nodularis. Photodermatol Photoimmunol Photomed. 2008;24(1):43–45.
- Wong SS, Goh CL. Double-blind, right/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of prurigo nodularis. Arch Dermatol. 2000;136(6):807–808.
- Pacifico A, Daidone R, Peris K. A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis. J Eur Acad Dermatol Venereol. 2006;20(2):153–157.
- Abadia Molina F, Burrows NP, Jones RR, Terenghi G, Polak JM. Increased sensory neuropeptides in nodular prurigo: A quantitative immunohistochemical analysis. Br J Dermatol. 1992;127(4):344–351.